Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)
نویسندگان
چکیده
Comprehensive Gynecologic Cancer Center, Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam, Korea Center for Uterine Cancer, National Cancer Center, Goyang, Korea Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea
منابع مشابه
Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers
The Surgery Treatment Modality Committee of the Korean Gynecologic Oncology Group has determined to develop a surgical manual to facilitate clinical trials and to improve communication between investigators by standardizing and precisely describing operating procedures. The literature on anatomic terminology, identification of surgical components, and surgical techniques were reviewed and discu...
متن کاملFIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
ments have challenged traditional concepts in ovarian cancer. First, it was recognized that ovarian cancer is not a homogeneous disease, but rather a group of diseases-each with different morphology and biological behavior. Approximately 90% of ovarian cancers are carcinomas (malignant epithelial tumors) and, based on histopathology, immunohistochemistry, and molecular genetic analysis, at leas...
متن کاملStaging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma
To the editor: We read with interest the almost identical articles on staging classification for ovarian and fallopian tube cancer that were published in several journals [1-8]. What is missing in the staging classification is the in situ carcinoma or Tis for ovary and fallopian tube. Cancer staging is important and necessary for explaining epidemiologic changes, defining the disease at present...
متن کاملSociety of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Women with germline mutations in the cancer susceptibility genes, BRCA1 or BRCA2, associated with Hereditary Breast & Ovarian Cancer syndrome, have up to an 85% lifetime risk of breast cancer and up to a 46% lifetime risk of ovarian, tubal, and peritoneal cancers. Similarly, women with mutations in the DNA mismatch repair genes, MLH1, MSH2, MSH6, or PMS2, associated with the Lynch/Hereditary No...
متن کامل2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
Cancer staging is a core principle in understanding the severity of patients' clinical condition, predicting the outcome, and planning adequate treatment. Staging is necessary for explaining epidemiologic changes, defining the disease at presentation, and evaluating the overall impact of new therapies. In essence, it assigns patients to prognostic groups that require specific treatments. The st...
متن کامل